UPDATE 1-AbbVie profit beats estimates on surging Humira sales
July 25, 2014 at 08:31 AM EDT
July 25 (Reuters) - AbbVie Inc, which last week announced plans to buy Dublin-based drugmaker Shire Plc for $55 billion, reported stronger-than-expected quarterly results on surging sales of its Humira treatment for rheumatoid arthritis.